It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: Grenade
a reply to: ScepticScot
Provide me with sources of data which you would like a comparison drawn from and i'll do so without bias.
I need a frame of reference, factors, features and outcomes.
originally posted by: ScepticScot
originally posted by: Grenade
a reply to: ScepticScot
Provide me with sources of data which you would like a comparison drawn from and i'll do so without bias.
I need a frame of reference, factors, features and outcomes.
You look at the effectivness of vaccine on the population you wish to consider.
You look at likelihood of comparable reaction from vaccine for same population.
You may want to consider weighting between outcomes.
The point being you have to compare vaccines and the virus to understand the risks and benefits.
originally posted by: Grenade
a reply to: ScepticScot
You're a big boy, i'm sure you can fight your own corner without resorting to mud slinging.
I'm reading back through the thread now, there's every chance i might call out Asmodeus for something as well.
Despite what you might think, my brusque approach to debate is generally civil.
originally posted by: Asmodeus3
originally posted by: ScepticScot
originally posted by: Grenade
a reply to: ScepticScot
Provide me with sources of data which you would like a comparison drawn from and i'll do so without bias.
I need a frame of reference, factors, features and outcomes.
You look at the effectivness of vaccine on the population you wish to consider.
You look at likelihood of comparable reaction from vaccine for same population.
You may want to consider weighting between outcomes.
The point being you have to compare vaccines and the virus to understand the risks and benefits.
You don't compare vaccines to viruses just as your fellow vaccine apologists do. The risk to benefit analysis is something very different and takes into account whether some age or risks groups wil be benefited by vaccination. Not how many people will be killed by either of them.
originally posted by: Asmodeus3
a reply to: ScepticScot
The risk to benefit analysis has been covered in one of my threads here
"The mathematics of adverse events of special interest following mRNA Covid-19 vaccination"
It features a well known peer reviewed paper.
originally posted by: ScepticScot
originally posted by: Asmodeus3
originally posted by: ScepticScot
originally posted by: Grenade
a reply to: ScepticScot
Provide me with sources of data which you would like a comparison drawn from and i'll do so without bias.
I need a frame of reference, factors, features and outcomes.
You look at the effectivness of vaccine on the population you wish to consider.
You look at likelihood of comparable reaction from vaccine for same population.
You may want to consider weighting between outcomes.
The point being you have to compare vaccines and the virus to understand the risks and benefits.
You don't compare vaccines to viruses just as your fellow vaccine apologists do. The risk to benefit analysis is something very different and takes into account whether some age or risks groups wil be benefited by vaccination. Not how many people will be killed by either of them.
How do they work out if they would benefit without comparing?
originally posted by: Grenade
a reply to: ScepticScot
No, you would need data preferably from an independent laboratory study which compares unvaccinated outcomes of infection with those vaccinated. Nobody in the medical industry is going to fund such a study, why kill your own cash cow.
If they vaccines offer any benefit at all the fact we're even having this conversation suggests it's minimal.
Until such data is available and such studies are carried out we'll simply never know. If only Pfizer hadn't vaccinated the test subjects before generating the data and rendering the results useless.
originally posted by: ScepticScot
originally posted by: Asmodeus3
a reply to: ScepticScot
The risk to benefit analysis has been covered in one of my threads here
"The mathematics of adverse events of special interest following mRNA Covid-19 vaccination"
It features a well known peer reviewed paper.
Yet you still can't answer how they do it without comparing.
Strange that.
originally posted by: Asmodeus3
originally posted by: ScepticScot
originally posted by: Asmodeus3
originally posted by: ScepticScot
originally posted by: Grenade
a reply to: ScepticScot
Provide me with sources of data which you would like a comparison drawn from and i'll do so without bias.
I need a frame of reference, factors, features and outcomes.
You look at the effectivness of vaccine on the population you wish to consider.
You look at likelihood of comparable reaction from vaccine for same population.
You may want to consider weighting between outcomes.
The point being you have to compare vaccines and the virus to understand the risks and benefits.
You don't compare vaccines to viruses just as your fellow vaccine apologists do. The risk to benefit analysis is something very different and takes into account whether some age or risks groups wil be benefited by vaccination. Not how many people will be killed by either of them.
How do they work out if they would benefit without comparing?
You don't make the comparisons the vaccine apologists do. How many people have been killed by the vaccines and how many people have been killed by the virus.
"The mathematics of adverse events of special interest following mRNA Covid-19 vaccination"
Take a look.
originally posted by: Asmodeus3
originally posted by: ScepticScot
originally posted by: Asmodeus3
a reply to: ScepticScot
The risk to benefit analysis has been covered in one of my threads here
"The mathematics of adverse events of special interest following mRNA Covid-19 vaccination"
It features a well known peer reviewed paper.
Yet you still can't answer how they do it without comparing.
Strange that.
I have already answered and it is in my thread which I have created long time ago. It's all yours and take a look.
originally posted by: ScepticScot
originally posted by: Asmodeus3
a reply to: ScepticScot
The risk to benefit analysis has been covered in one of my threads here
"The mathematics of adverse events of special interest following mRNA Covid-19 vaccination"
It features a well known peer reviewed paper.
Yet you still can't answer how they do it without comparing.
Strange that.
originally posted by: Grenade
a reply to: ScepticScot
I don't know those members or have an insight into their character. Carpy on the other hand is generally civil, even if he's annoying as hell.
He also posted a very similar critique of a post i made which i redacted after reconsidering my approach. Two wrongs don't make a right. I don't see how reducing the thread to insults benefits anyone, unless that's the intention?